Nutr Res Pract.  2014 Oct;8(5):550-557. 10.4162/nrp.2014.8.5.550.

Bioavailability of plant pigment phytochemicals in Angelica keiskei in older adults: A pilot absorption kinetic study

Affiliations
  • 1Jean Mayer USDA- Human Nutrition Research Center on Aging, Tufts University, 711 Washington St., Boston, MA 02111, USA.
  • 2Department of Internal Medicine, Botucatu Medical School, Sao Paulo State University (UNESP), Distrito Rubiao Jr. s/n, 18618-970 Botucatu, SP, Brazil.
  • 3Department of Pharmaceutical Sciences, Universita degli Studi di Milano, 20133 Milan, Italy.
  • 4National Academy of Agricultural Science, Rural Development Administration, Suwon 441-853, Republic of Korea.
  • 5College of Biomedical and Health Sciences, Konkuk University, Chungju-si, 380-701, Republic of Korea. kyeum@kku.ac.kr

Abstract

BACKGROUND/OBJECTIVES
Angelica keiskei is a green leafy vegetable rich in plant pigment phytochemicals such as flavonoids and carotenoids. This study examined bioavailability of flavonoids and carotenoids in Angelica keiskei and the alteration of the antioxidant performance in vivo. SUBJECTS AND MATERIALS: Absorption kinetics of phytochemicals in Angelica keiskei were determined in healthy older adults (> 60 y, n = 5) and subjects with metabolic syndrome (n = 5). Subjects consumed 5 g dry Angelica keiskei powder encapsulated in gelatin capsules with a low flavonoid and carotenoid liquid meal. Plasma samples were collected at baseline, 0.5, 1, 2, 3, 4, 5, 6, 7, and 8 h. Samples were analyzed for flavonoids and carotenoids using HPLC systems with electrochemical and UV detection, respectively, and for total antioxidant performance by fluorometry.
RESULTS
After ingestion of Angelica keiskei increases in plasma quercetin concentrations were observed at 1-3 and 6-8 hr in the healthy group and at all time points in the metabolic syndrome group compared to baseline (P < 0.05). Plasma lutein concentrations were significantly elevated in both the healthy and metabolic syndrome groups at 8 hr (P < 0.05). Significant increases in total antioxidant performance were also observed in both the healthy and the metabolic syndrome groups compared to baseline (P < 0.05).
CONCLUSIONS
Findings of this study clearly demonstrate the bioavailability of phytonutrients of Angelica keiskei and their ability to increase antioxidant status in humans.

Keyword

Angelica keiskei; quercetin; lutein; absorption kinetic; total antioxidant performance

MeSH Terms

Absorption*
Adult*
Angelica*
Biological Availability*
Capsules
Carotenoids
Chromatography, High Pressure Liquid
Eating
Flavonoids
Fluorometry
Gelatin
Humans
Kinetics
Lutein
Meals
Phytochemicals*
Plants*
Plasma
Quercetin
Vegetables
Capsules
Carotenoids
Flavonoids
Gelatin
Lutein
Quercetin

Figure

  • Fig. 1 Absorption kinetics of quercetin in plasma after ingesting 5 g of Angelica keiskei in older adults (aged ≥ 60 yr); healthy (A) and metabolic syndrome (B). Data are expressed as mean ± SEM (n = 5 in each group). ND, not detected. One-way repeated measures ANOVA with Tukey's multiple comparison was performed. When an equal variance test failed, Friedman repeated measures analysis of variance on ranks with Tukey's multiple comparison test was used. Significantly different as compared with the baseline *P < 0.05. Samples were analyzed by HPLC with ECD detection for quercetin.

  • Fig. 2 Absorption kinetics of lutein in plasma after ingesting 5 g of Angelica keiskei in older adults (aged ≥ 60 yr); healthy (A) and metabolic syndrome (B). Data are expressed as mean ± SEM (n = 5 in each group). One-way repeated measures ANOVA with Tukey's multiple comparison was performed. Significantly different as compared with the baseline *P < 0.05. Samples were analyzed by HPLC with UV detection.

  • Fig. 3 Plasma total antioxidant performance after ingesting 5 g of Angelica keiskei in older adults (aged ≥ 60 yr); healthy (A) and metabolic syndrome (B). Data are expressed as mean ± SEM (n = 5 in each group). One-way repeated measures ANOVA with Tukey's multiple comparison was performed. When an equal variance test failed, Friedman repeated measures analysis of variance on ranks with Tukey's multiple comparison test was used. Significantly different as compared with the baseline *P < 0.05. Samples were analyzed by fluorometry.


Reference

1. Hata K, Kozawa M. Pharmacognostical studies on umbelliferous plants. XVIII. On the constituents of the roots of Angelica Keiskei Koidzumi. Yakugaku Zasshi. 1961; 81:1647–1649.
Article
2. Kozawa M, Morita N, Baba K, Hata K. Chemical components of the roots of Angelica keiskei Koidzumi. II. The structure of the chalcone derivatives (author's transl). Yakugaku Zasshi. 1978; 98:210–214.
Article
3. Kozawa M, Morita N, Baba K, Hata K. Chemical components of the roots of Angelica keiskei Koidzumi. III. The structure of a new dihydrofurocoumarin (author's transl). Yakugaku Zasshi. 1978; 98:636–638.
Article
4. Motani K, Tabata K, Kimura Y, Okano S, Shibata Y, Abiko Y, Nagai H, Akihisa T, Suzuki T. Proteomic analysis of apoptosis induced by xanthoangelol, a major constituent of Angelica keiskei, in neuroblastoma. Biol Pharm Bull. 2008; 31:618–626.
Article
5. Kimura Y. New anticancer agents: in vitro and in vivo evaluation of the antitumor and antimetastatic actions of various compounds isolated from medicinal plants. In Vivo. 2005; 19:37–60.
6. Akihisa T, Tokuda H, Hasegawa D, Ukiya M, Kimura Y, Enjo F, Suzuki T, Nishino H. Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects. J Nat Prod. 2006; 69:38–42.
Article
7. Fujita T, Sakuma S, Sumiya T, Nishida H, Fujimoto Y, Baba K, Kozawa M. The effects of xanthoangelol E on arachidonic acid metabolism in the gastric antral mucosa and platelet of the rabbit. Res Commun Chem Pathol Pharmacol. 1992; 77:227–240.
8. Inamori Y, Baba K, Tsujibo H, Taniguchi M, Nakata K, Kozawa M. Antibacterial activity of two chalcones, xanthoangelol and 4-hydroxyderricin, isolated from the root of Angelica keiskei KOIDZUMI. Chem Pharm Bull (Tokyo). 1991; 39:1604–1605.
Article
9. Kawabata K, Sawada K, Ikeda K, Fukuda I, Kawasaki K, Yamamoto N, Ashida H. Prenylated chalcones 4-hydroxyderricin and xanthoangelol stimulate glucose uptake in skeletal muscle cells by inducing GLUT4 translocation. Mol Nutr Food Res. 2011; 55:467–475.
Article
10. Shimizu E, Hayashi A, Takahashi R, Aoyagi Y, Murakami T, Kimoto K. Effects of angiotensin I-converting enzyme inhibitor from Ashitaba (Angelica keiskei) on blood pressure of spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo). 1999; 45:375–383.
Article
11. Kang MH, Park YK, Kim HY, Kim TS. Green vegetable drink consumption protects peripheral lymphocytes DNA damage in Korean smokers. Biofactors. 2004; 22:245–247.
Article
12. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr. 2005; 81:243S–255S.
Article
13. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr. 2005; 81:230S–242S.
Article
14. Aldini G, Regazzoni L, Pedretti A, Carini M, Cho SM, Park KM, Yeum KJ. An integrated high resolution mass spectrometric and informatics approach for the rapid identification of phenolics in plant extract. J Chromatogr A. 2011; 1218:2856–2864.
Article
15. Li L, Aldini G, Carini M, Oliver Chen CY, Chun HK, Cho SM, Park KM, Correa CR, Russell RM, Blumberg JB, Yeum KJ. Characterisation, extraction efficiency, stability and antioxidant activity of phytonutrients in Angelica keiskei. Food Chem. 2009; 115:227–232.
Article
16. Yeum KJ, Aldini G, Chung HY, Krinsky NI, Russell RM. The activities of antioxidant nutrients in human plasma depend on the localization of attacking radical species. J Nutr. 2003; 133:2688–2691.
Article
17. Yeum KJ, Beretta G, Krinsky NI, Russell RM, Aldini G. Synergistic interactions of antioxidant nutrients in a biological model system. Nutrition. 2009; 25:839–846.
Article
18. Aldini G, Yeum KJ, Russell RM, Krinsky NI. A method to measure the oxidizability of both the aqueous and lipid compartments of plasma. Free Radic Biol Med. 2001; 31:1043–1050.
Article
19. Beretta G, Aldini G, Facino RM, Russell RM, Krinsky NI, Yeum KJ. Total antioxidant performance: a validated fluorescence assay for the measurement of plasma oxidizability. Anal Biochem. 2006; 354:290–298.
Article
20. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 2004; 27:2444–2449.
Article
21. Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report. 2009; 1–7.
22. Ford ES, Schulze MB, Pischon T, Bergmann MM, Joost HG, Boeing H. Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study. Cardiovasc Diabetol. 2008; 7:35.
Article
23. Grundy SM. A constellation of complications: the metabolic syndrome. Clin Cornerstone. 2005; 7:36–45.
24. Malone DC, Boudreau DM, Nichols GA, Raebel MA, Fishman PA, Feldstein AC, Ben-Joseph RH, Okamoto LJ, Boscoe AN, Magid DJ. Association of cardiometabolic risk factors and prevalent cardiovascular events. Metab Syndr Relat Disord. 2009; 7:585–593.
Article
25. Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, Kontush A. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab. 2004; 89:4963–4971.
Article
26. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes. 2003; 52:2346–2352.
27. Coyne T, Ibiebele TI, Baade PD, McClintock CS, Shaw JE. Metabolic syndrome and serum carotenoids: findings of a cross-sectional study in Queensland, Australia. Br J Nutr. 2009; 102:1668–1677.
Article
28. Zhao X, Aldini G, Johnson EJ, Rasmussen H, Kraemer K, Woolf H, Musaeus N, Krinsky NI, Russell RM, Yeum KJ. Modification of lymphocyte DNA damage by carotenoid supplementation in postmenopausal women. Am J Clin Nutr. 2006; 83:163–169.
Article
29. Behrens WA, Madère R. A highly sensitive high-performance liquid chromatography method for the estimation of ascorbic and dehydroascorbic acid in tissues, biological fluids, and foods. Anal Biochem. 1987; 165:102–107.
Article
30. Fossati P, Prencipe L, Berti G. Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem. 1980; 26:227–231.
Article
31. Chen CY, Milbury PE, Lapsley K, Blumberg JB. Flavonoids from almond skins are bioavailable and act synergistically with vitamins C and E to enhance hamster and human LDL resistance to oxidation. J Nutr. 2005; 135:1366–1373.
Article
32. Cho YS, Yeum KJ, Chen CY, Beretta G, Tang G, Krinsky NI, Yoon S, Lee-Kim YC, Blumberg JB, Russell RM. Phytonutrients affecting hydrophilic and lipophilic antioxidant activities in fruits, vegetables and legumes. J Sci Food Agric. 2007; 87:1096–1107.
Article
33. Zhang Z, Kou X, Fugal K, McLaughlin J. Comparison of HPLC methods for determination of anthocyanins and anthocyanidins in bilberry extracts. J Agric Food Chem. 2004; 52:688–691.
Article
34. Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, D.C.: The National Academies Press;2000.
35. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. International Diabetes Federation Task Force on Epidemiology and Prevention. Hational Heart, Lung, and Blood Institute. American Heart Association. World Heart Federation. International Atherosclerosis Society. International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120:1640–1645.
36. Torres S, Salgado-Ceballos H, Torres JL, Orozco-Suarez S, Díaz-Ruíz A, Martínez A, Rivera-Cruz M, Ríos C, Lara A, Collado C, Guizar-Sahagún G. Early metabolic reactivation versus antioxidant therapy after a traumatic spinal cord injury in adult rats. Neuropathology. 2010; 30:36–43.
Article
37. Montonen J, Knekt P, Järvinen R, Reunanen A. Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care. 2004; 27:362–366.
Article
38. Graefe EU, Wittig J, Mueller S, Riethling AK, Uehleke B, Drewelow B, Pforte H, Jacobasch G, Derendorf H, Veit M. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol. 2001; 41:492–499.
Article
39. Wiczkowski W, Romaszko J, Bucinski A, Szawara-Nowak D, Honke J, Zielinski H, Piskula MK. Quercetin from shallots (Allium cepa L. var. aggregatum) is more bioavailable than its glucosides. J Nutr. 2008; 138:885–888.
Article
40. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE, Gewirtz AT. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010; 328:228–231.
Article
41. Dey A, Williams RS, Pollock DM, Stepp DW, Newman JW, Hammock BD, Imig JD. Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria. Obes Res. 2004; 12:1278–1289.
Article
42. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004; 114:1752–1761.
Article
43. van Het Hof KH, West CE, Weststrate JA, Hautvast JG. Dietary factors that affect the bioavailability of carotenoids. J Nutr. 2000; 130:503–506.
Article
44. van den Berg H. Effect of lutein on beta-carotene absorption and cleavage. Int J Vitam Nutr Res. 1998; 68:360–365.
45. Kostic D, White WS, Olson JA. Intestinal absorption, serum clearance, and interactions between lutein and beta-carotene when administered to human adults in separate or combined oral doses. Am J Clin Nutr. 1995; 62:604–610.
Article
46. Marisiddaiah R, Baskaran V. Bioefficacy of beta-carotene is improved in rats after solubilized as equimolar dose of beta-carotene and lutein in phospholipid-mixed micelles. Nutr Res. 2009; 29:588–595.
Article
47. Talegawkar SA, Beretta G, Yeum KJ, Johnson EJ, Carithers TC, Taylor HA Jr, Russell RM, Tucker KL. Total antioxidant performance is associated with diet and serum antioxidants in participants of the diet and physical activity substudy of the Jackson Heart Study. J Nutr. 2009; 139:1964–1971.
Article
48. Dragsted LO, Pedersen A, Hermetter A, Basu S, Hansen M, Haren GR, Kall M, Breinholt V, Castenmiller JJ, Stagsted J, Jakobsen J, Skibsted L, Rasmussen SE, Loft S, Sandström B. The 6-a-day study: effects of fruit and vegetables on markers of oxidative stress and antioxidative defense in healthy nonsmokers. Am J Clin Nutr. 2004; 79:1060–1072.
Article
49. McKay DL, Chen CY, Yeum KJ, Matthan NR, Lichtenstein AH, Blumberg JB. Chronic and acute effects of walnuts on antioxidant capacity and nutritional status in humans: a randomized, cross-over pilot study. Nutr J. 2010; 9:21.
Article
Full Text Links
  • NRP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr